🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 1 first-in-human single ascending dose study will be a randomize...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-08
Trial ID
NCT02531815
Treatments Being Tested
This is a phase 1, first in human, randomized, double-blind, placebo-contro...
Status
Completed
Location
Frontage Clinical Research Center
Start Date
2023-04-17
Trial ID
NCT05724797
This is a randomized, placebo-controlled, multiple dose escalation study to...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT03006159
This is a single center, double-blinded, randomized, placebo controlled sin...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2022-06-06
Trial ID
NCT06769620
To Evaluate the Safety, Tolerability and Pharmacokinetics on DA-302168S Tab...
Status
Completed
Location
Gulou Hospital Affiliated to Nanjing Medical University
Start Date
2024-04-18
Trial ID
NCT06534320
Treatments Being Tested
The purpose of this study is to examine the safety and tolerability of HFB3...
Status
Completed
Location
Huashan Hospital
Start Date
2021-05-09
Trial ID
NCT05275660
A safety study of KAN-101 in patients with celiac disease. The study has tw...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2020-01-21
Trial ID
NCT04248855
This is a prospective, double-blind, randomized, placebo-controlled study i...
Status
Terminated
Location
Sanford Health
Start Date
2020-05-14
Trial ID
NCT04372017
Treatments Being Tested
The purpose of this study is to determine whether NNZ-2566 is safe and effe...
Status
Completed
Location
University of South Alabama
Start Date
2010-04
Trial ID
NCT00805818
This is a Phase 1 study to assess the the safety, tolerability and pharmaco...
Status
Completed
Location
Research Site
Start Date
2022-04-04
Trial ID
NCT05351047
Treatments Being Tested